Eris Lifesciences Limited (NSEI: ERIS)
Health Care · Pharmaceuticals · IN
Rs1,170.70
-1.61% today · -27.3% 1Y
Eris Lifesciences Limited (NSEI: ERIS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.68B and employs 2,758 people.
Over the last twelve months the share price has lost 27.3%, trading between 1.14K and 1.74K.
Tweenvest scores Eris Lifesciences Limited across four factors: quality 77/100, value 68/100, growth 71/100, dividend 50/100. Its strongest factor is quality.
ERIS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.68B
- Revenue (TTM)
- $339.75M
- P/E
- 24.99
- EPS
- 46.85
- Dividend yield
- 0.62%
- Beta (5Y)
- -0.03
- 52-week high
- Rs1,740.00
- 52-week low
- Rs1,141.00
- Avg volume (3M)
- —
- Shares outstanding
- 138.74M
- Employees
- 2,758
- Next earnings
- —
About Eris Lifesciences Limited
Eris Lifesciences Limited is an Indian pharmaceutical company engaged in the manufacturing, marketing, and distribution of medicinal products throughout the country. The company provides a comprehensive range of branded formulations, catering to a wide spectrum of therapeutic areas. These encompass cardiovascular health, anti-diabetic treatments, anti-infectives, antipyretics, vitamin/nutrient supplements, gastroenterology, respiratory care, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, alongside services in in-vitro fertilization, cosmetology, and dermatology. Founded in 2007, Eris Lifesciences Limited is headquartered in Ahmedabad, India.
- ISIN
- INE406M01024
- Founded
- 2007
- Listed since
- Jun 30, 2017
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cohance Lifesciences LimitedNSEI: COHANCE | $1.74B | Rs441.00 | -2.28% |
| Shanghai Shyndec Pharmaceutical Co., Ltd.SHSE: 600420 | $1.70B | CN¥8.51 | +1.43% |
| Faes Farma, S.A.BME: FAE | $1.69B | €4.89 | +0.82% |
| Alivus Life Sciences LimitedNSEI: ALIVUS | $1.68B | Rs1,326.30 | -3.49% |
| Bora Pharmaceuticals Co., Ltd.TWSE: 6472 | $1.68B | NT$421.00 | +0.12% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd.SHSE: 600572 | $1.67B | CN¥4.41 | +2.32% |
| Henan Lingrui Pharmaceutical Co., Ltd.SHSE: 600285 | $1.66B | CN¥19.66 | +3.04% |
| Hanall Biopharma Co., Ltd.KOSE: A009420 | $1.66B | ₩44,000.00 | -4.56% |
Figures last refreshed Oct 11, 2026.